In a press release, Medtronic announced that the FDA approved the first step in getting an artificial pancreas to the US market. Though the 530G with Enlite (called the Paradigm Veo elsewhere) has been in use in Europe for about 2 years, the technology will finally arrive in the US.
The 530G is the first pump to automatically stop insulin when the user is low and doesn’t respond to alarms. This is a big step towards a closed loop system.
WIll you be upgrading?